Search Weight Loss Topics:

Page 32«..1020..31323334..4050..»

Category Archives: Testosterone

LPCN: Tlando: Target Action Date This Friday – Zacks Small Cap Research

Posted: August 27, 2020 at 2:56 pm

By John Vandermosten

NASDAQ:LPCN

READ THE FULL LPCN RESEARCH REPORT

Up and Coming Milestones

Tlando PDUFA date August 28, 2020

Primary endpoint results for LiFT (LPCN 1144) 4Q:20

Patent Infringement trial February 2021

Complete Phase II LiFT (LPCN 1144) 2Q:21

Second Quarter 2020 Operational and Financial Results

On August 6, 2020 Lipocine (NASDAQ:LPCN) filed its second quarter 2020 10-Q and posted its earnings release for the three month period ending June 30, 2020. The company reported zero revenues and a net loss per share of ($0.13) compared to prior year revenues of zero and loss of ($0.14) per share. Activity during the second quarter revolved around several items including presentation at the American Urological Association (AUA) conference, demonstration of treatment potential for LPCN 1144, investigational new drug clearance for LPCN 1148, affirmation of the USPTO decision and the dismissal of a shareholder lawsuit. The companys shares also exceeded $1.00 in June, and have remained above this level, allowing Lipocine to regain compliance with NASDAQ minimum bid requirements. The most important item on the calendar is the FDAs response to Tlandos NDA submission, which is expected on or before August 28th.

We anticipate that upon approval, Lipocine will find a partner to commercialize Tlando and use associated upfront and milestone payments to further develop the existing portfolio, especially LPCN 1144 and LPCN 1148. Potential licensees are waiting until approval is granted before performing their due diligence. This suggests that a deal would be announced in the fourth quarter of 2020 rather than in the weeks following an assumed approval.

Operational expenses for 2Q:20 were $4.2 million, up 26% and net loss totaled ($6.4) million or ($0.13) per share. Research and development expenses totaled $2.5 million. The 16% rise over prior year amounts reflects increased costs related to the LiFT study and higher personnel expenditures offset by a decrease in amounts related to the ABPM study, lower spend on the Tlando XR program and a fall in manufacturing costs for LPCN 1107. General and administrative costs rose 41% over last years second quarter to $2.0 million on an expansion in legal expenditures related to the Clarus dispute and an increase in personnel costs offset by lower marketing expenses, administrative travel and other expenses. A rise in the share price increased the warrant liability and required the recognition of a $2.1 million non-cash loss in other income.

Cash and marketable securities balance was $18.2 million as of June 30, 2020. There is another $5 million of restricted1 cash which will remain on hold until Tlando is approved. Current and non-current debt is carried on the balance sheet at $6.3 million. Cash burn for 2Q:20 was approximately ($4.1) million and net cash provided by financing was $11.7 million representing a stock offering and warrant proceeds partially offset by a small amount of debt repayment.

Tlando

On November 11 of last year, Lipocine announced that it had received a complete response letter (CRL) for Tlando. The CRL identified one deficiency stating that the trial did not meet one of the three secondary endpoints for maximal testosterone concentrations (Cmax). No deficiencies related to chemistry, manufacturing and controls were noted. FDA guidelines call for 85% of subjects to achieve a Cmax below 1500 ng/dL and no more than 5% of subjects presenting a Cmax between 1800 ng/dL and 2500 ng/dL and 0% above 2500 ng/dL. In the most recent dosing validation (DV) study, 85% of subjects were below 1500 ng/dL and 7% were between 1800 ng/dL and 2500 ng/dL. Although there were small variations from the FDA guidelines in the original SOAR study for subjects above 2500 ng/dL, the FDA did not identify these as a deficiency during the original New Drug Application (NDA) submission.

Following the Post Action meeting with the FDA, Lipocine was advised to address the outstanding deficiencies with a reanalysis of existing data. This recommendation relieved Lipocine of the time and cost of an additional trial and also allowed the resubmission of the Tlando NDA in February. A target action date of August 28th was provided. While the resubmission is a positive, Tlando has faced significant hurdles gaining the favor of the FDA. We published a note on February 25th that discussed details regarding the resubmission.

LPCN 1144

Lipocine announced in August 2018 the pursuit of a new indication in nonalcoholic steatohepatitis (NASH). We discuss the indication and Lipocines efforts in an earlier piece that can be accessed here. Full enrollment of 36 subjects was achieved in November 2018.

In January 2019, Lipocine announced meaningful liver fat reduction in patients participating in its Liver Fat Study and informed investors that the company had filed an investigational new drug (IND) application to begin a Phase II study for NASH. Since LPCN 1144 is the same molecule as TLANDO, for which there were numerous safety studies completed, LPCN was allowed to perform a proof of concept (POC) clinical study under the original IND to assess liver fat changes. This 36-person study was conducted in hypogonadal men at risk of developing non-alcoholic steatohepatitis (NASH) and results were measured using the magnetic resonance imaging proton density fat fraction (MRI-PDFF) technique. Topline results were announced in 1Q:19 demonstrating a 4.0% to 8.2% percentage point reduction in liver fat depending on baseline liver fat category. We discussed the results in further detail in our NASH Topline article.

Lipocine launched its Phase II clinical study for LPCN 1144 and dosed its first patient last September. Prior to the start of the trial, Lipocine announced that the FDA would allow the Phase II LiFT trial to enroll eugonadal patients in addition to the NASH patients that were initially targeted. This expansion was based on research that we discussed in a July 29th note. The study is anticipated to last for 18 months and cost approximately $8 million.

LiFT, an acronym of Liver Fat intervention with oral Testosterone, is a paired biopsy Phase II study in NASH subjects. The study design will employ a three-arm, double-blind, placebo-controlled structure and enroll approximately 75 biopsy confirmed male NASH subjects with a NAS2 score of greater or equal to four. The primary endpoint for the study is 12-week MRI-PDFF liver fat reduction and the first patient was enrolled in 3Q:19. As for the anticipated timeline, Lipocine expects top line liver fat reduction data in 4Q:20 as measured by MRI-PDFF at 12 weeks. Biopsy data at 36 weeks is expected to be available in the second quarter of 2021.

Exhibit I LiFT Study Timeline3

NASH Environment

A lot has happened in the NASH space in 2020. Genfit (GNFT) announced that it will halt development of elafibranor after it failed to distinguish itself compared to placebo earlier this year. CymaBay (CBAY) announced that the FDA had lifted the hold on seladelpars Phase II study last month. No evidence was found for liver injury for the drug and the trial is expected to resume. Intercepts (ICPT) OCA received a complete response letter from the FDA in late June noting that the agency remains uncertain that the benefits of the drug outweigh the risks. Viking (VKTX) is conducting the Phase IIb VOYAGE trial for VK2809 which is still ongoing. A bright spot in the space has been results from Akeros (AKRO) Phase IIb trial for efruxifermin in NASH which were announced June 30. The study found that 48% of patients had fibrosis improvement of at least one stage with a 62% response rate. Fibrosis improved by at least two stages for 28% of the group with a 38% response rate and 48% experienced NASH resolution without worsening of fibrosis across all dose groups.

LPCN 1148

Lipocine is preparing to develop its testosterone molecule to treat NASH cirrhosis patients. While the target market is smaller than that of pre-cirrhotic NASH, there are no other FDA approved products available. The inverse relationship between testosterone and sarcopenia and the increased risks of advancing NASH cirrhosis validates this pursuit. Pending funding, Lipocine plans to initiate a proof of concept trial to evaluate the potential of this candidate. The companys Investigational New Drug (IND) application was cleared by the FDA in May 2020. We anticipate Lipocine will launch the Phase II trial after the start of commercialization of Tlando and upon availability of sufficient capital to fund it. Management has guided to a 4Q:20 or 1Q:21 start.

Exhibit II Lipocine Pipeline4

Markman Hearing

On March 26th, Lipocine announced the outcome of the Markman Hearing, also known as a claim construction hearing. This meeting is an important precursor to a patent infringement lawsuit and provides the definitions of terms critical for a jurys determination on whether or not a patent has value. A patent should not be too specific, as it provides insufficient protection to an invention, or too broad, in which case a court may rule it indefinite. In the hearing order5, Judge Bryson did not agree with most of Clarus claims and sided with Lipocine on the majority of definitions and clarifications. While the terms and definitions are subject to an evolving construction, the order is favorable to Lipocines dispute against Clarus. While this order could be appealed again, it is unlikely in the opinion of Lipocines counsel. Lipocine and Clarus are currently engaged in the fact discovery phase of the lawsuit and the jury trial is anticipated to take place in February 2021. Lipocine need only prevail on one claim to merit damages, which places them in a strong position to succeed in the trial or provide incentive for Clarus to settle.

USPTO Decision Affirmed

The US Court of Appeals affirmed the decision of the USPTO in April 2020 to grant Lipocines Priority Motion in the interference case that cancelled Clarus claims to the 428 patent in January 2019. The USPTO, through its Patent Trial and Appeal Board (PTAB), had granted Lipocines priority motion in the related interference case and entered adverse judgment against Clarus. As we have previously shared, this outcome was expected as it is rare for a federal court to overturn a USPTO ruling. As a reminder, in 2Q:19 Lipocinefiled suitagainst Clarus alleging that Jatenzo infringed on six of Lipocines patents. The injunction filing may slow down commercialization of Jatenzo and force Clarus to come to the table to negotiate a settlement. While the cost of pursuing such legal action could be high, we anticipate by the time the case works its way through the courts, cash flow from Tlando could be sufficient to support the legal efforts.

Publications and Abstracts

Results from Lipocines Liver Fat Study were published in Hepatology Communications in an article entitled LPCN 1144 Resolves Non-Alcoholic Fatty Liver Disease In Hypogonadal Males." The study served to identify the prevalence of non-alcoholic fatty liver disease (NAFLD) in hypogonadal males and quantify the beneficial impact of LPCN 1144 on hypogonadism. 36 hypogonadal males were evaluated using MRI-PDFF measurements for liver fat. 81% of those with baseline liver fat equal to or greater than 5% showed improvement in liver fat content and NAFLD resolved in one-third of the group at six weeks and 48% after 16 weeks. The paper concluded that treatment with LPCN 1144 resolved NAFLD in about half of affected patients without any safety signals.

Lipocine submitted several abstracts to the American Urological Association (AUA) Virtual Experience, which took place from May 15 to 17, 2020. Three titles were presented.

Impact of a new oral testosterone undecanoate on blood pressure and cardiovascular risk was presented by Dr. Mohit Khera which investigated the chronic use of testosterone replacement therapy (TRT) on cardiovascular risk. Jatenzo, Xyosted and Tlando were assessed in their impact on blood pressure and cardiovascular risk in hypogonadal men. Marginal increases in blood pressure were observed and no meaningful impact on cardiovascular risk was noted.

A novel oral testosterone therapy restores testosterone to eugonadal levels without dose titration was presented by Dr. Martin Miner and highlights the shortcomings of dose titration when prescribing TRT. The abstract concluded that fixed dose Tlando normalizes testosterone levels in hypogonadal patients while avoiding the potential problems associated with titrated TRT.

Effects of a new oral testosterone undecanoate (TLANDO) therapy on liver was presented by Dr. Irwin Goldstein and compares oral methyltestosterone (MT) with TRT in males deficient in endogenous testosterone. The study results suggested that unlike MT, Tlando has no adverse effects on liver and can be used for an extended period to potentially reduce liver fat.

Milestones

Tlando CRL November 9, 2019

Tlando FDA post action meeting January 2020

Resubmission of Tlando NDA February 2020

Investigational New Drug (IND) clearance for LPCN 1148 May 2020

Wajda v. Patel shareholder suit dismissed July 2020

Tlando PDUFA date August 28, 2020

Primary endpoint results for LiFT (LPCN 1144) 4Q:20

Patent Infringement trial February 2021

Complete Phase II LiFT (LPCN 1144) 2Q:21

Summary

Since our previous update, Lipocine has participated in scientific conferences, published an article in the journal Hepatology Communications and advanced several months towards the upcoming August 28 PDUFA date for Tlando. Assuming a favorable outcome for the application, Lipocine will seek a commercialization partner and should receive upfront and milestone proceeds in conjunction with a deal. The Phase II LiFT trial continues to be a bright spot for the company and is potentially able to address a large unmet need in NASH patients in contrast to other programs which have met with difficulty. Management has guided towards a year-end readout of LiFT trial results. Lipocine is also developing LPCN 1148 for cirrhosis patients which was recently given clearance to begin a Phase II study. While we do not see this program entering the clinic until sufficient capital is available, we do think it will advance if Phase II data for LPCN 1144 are positive.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCHtoreceive our articles and reports emailed directly to you each morning. Please visit ourwebsitefor additional information on Zacks SCR.

DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $40,000 annually for these services. Full Disclaimer HERE.

________________________

1. Tlando was not approved by the FDA by May 31, 2018, and therefore Lipocine is required to maintain $5.0 million of cash collateral at Silicon Valley Bank (the lender) until such time as it is approved by the FDA.

2. NAS: NAFLD (Non-alcoholic fatty liver disease) Activity Score. Discussion of the metric can be found here.

3. Source: Lipocine Corporate Presentation May 2020.

4. Source: Lipocine Corporate Presentation July 2020.

5. A link to the Markman Hearing Order can be found on this page: https://ir.lipocine.com/presentations

See the original post here:
LPCN: Tlando: Target Action Date This Friday - Zacks Small Cap Research

Posted in Testosterone | Comments Off on LPCN: Tlando: Target Action Date This Friday – Zacks Small Cap Research

Doctors find testicles in woman’s stomach that are in early stages of cancer – Mirror Online

Posted: August 27, 2020 at 2:56 pm

A woman was 'devastated' when she found out the reason she'd never had a period is because she's intersex - after doctors discovered she was missing a womb and had testicles inside her stomach.

Content creator and activist, Dani Coyle, 25, from Swindon, grew up suspecting that something made her different. As a young teen, Dani's voice suddenly dropped and whilst her peers began to get their first periods, Dani only developed terrible stomach cramps.

After seeking medical advice, Dani was sent to specialists who at age 14, diagnosed her as being intersex. This means that Dani has a deviation in her gender characteristics that does not match the 'traditional' understanding of the female body.

Dani was told she had a 17 beta-hydroxysteroid dehydrogenase three deficiency. Whilst she'd always appeared to be female, Dani didn't have the female hormones she required once she reached puberty and 'should have' been born as a cisgender male. This is when a person's gender identification matches their birth sex.

The doctors discovered that Dani had XY chromosomes usually found in men and no female reproductive organs such as a womb. A further scan revealed that she has testicles inside her stomach which were in the early stages of cancer.

Doctors told Dani that they could 'normalise' her 'medical defect' through surgery and hormone replacement therapy. In 2009, the suspected cancerous testes were removed and Dani underwent external cosmetic surgery to alter the appearance of her vulva.

Dani thought that the ordeal was over, but she later felt coerced into the surgery after quickly learning that intersex bodies aren't accepted by society.

At school, Dani began to experience transphobic comments as her peers would deem her to be a 'lady boy' and a 'tranny,' due to a lack of understanding on what it means to be intersex. Whilst Dani uses both female and gender-neutral pronouns, she identifies as female.

"When I was told that I'm intersex, in truth, I was devastated although not surprised," Dani said.

"I'd wished for words to explain and understand my differences for a long time. I was relieved but scared to finally have them.

"When I was ten, I noticed things changing in my body that were more typical of what happens in male development. My voice lowered in tone and my period never came. It was an extremely confusing and lonely time.

"At fourteen, I was told I had 'seventeen beta-hydroxysteroid dehydrogenase three' deficiency.

"My body didn't respond 'normally' to the testosterone my testes produced which is why I was born, looked like, and was raised as a girl which is lucky as I've always identified as female.

"I was scared no one was going to love me when I found out. I was angry at the odds why me? I was told and believed it to be a secret that no one needed to know so I quickly underwent the surgery to remove my testes and normalise my external appearance just as the doctors and surgeons recommended.

"I also had hormone replacement therapy which is essentially a menopause oestrogen pill and I thought I'd be back to being a normal girl. Now, I feel like these surgeries were presented as the only viable option like I was robbed by biased doctors who work within a biased system which has caused an immeasurable amount of mental trauma."

Dani is a keen activist and she hopes to raise awareness around intersex surgery particularly surgery performed on young children without their consent. She believes raising awareness in society through extended education in schools could be a part of the solution.

"We are robbed of bodily autonomy in the name of gender binary," said Dani. "For many, the idea there are only two sexes and genders is way more convenient disregarding those of us who don't fit in to 'either' and 'or.' If I had known then what I do know, I wonder if I would have chosen the surgeries or harboured as much and shame and disgust for myself, as I did for so long.

"I used to think being intersex was a curse but now I see that's a blessing. I am free from the confines of gender expectations. I'm a part of the sanctuary of the LGBTQIA+ community and I'm literally one in a million.

"These surgeries are forced upon intersex babies every day, many of whom end up with a gender identity that doesn't align with their body's presentation because it was chosen for them by someone else.

"Even now, I have intimacy issues and body dysmorphia due to the trauma of being poked and prodded so much as a child ` it was incredibly traumatic.

"I want to see representative education in schools that covers the whole spectrum of human biology. I want to see the end of non-consensual, cosmetic intersex genital surgeries on babies and children.

"I want to promote and see the world become more aware, accepting, and inclusive of intersex, trans, and gender non-conforming people and our use of language. Hopefully, I can play a small part in that.

"The differences in our bodies, identities, and cultures are things to celebrate. Let's all be kinder to people who are different from ourselves."

Visit link:
Doctors find testicles in woman's stomach that are in early stages of cancer - Mirror Online

Posted in Testosterone | Comments Off on Doctors find testicles in woman’s stomach that are in early stages of cancer – Mirror Online

Global Testosterone Replacement Therapy Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: AbbVie, Endo International, Eli…

Posted: August 19, 2020 at 10:58 pm

The Testosterone Replacement Therapy Market reports gives a far reaching review of the worldwide market size and global trends with values. Testosterone Replacement Therapy Market reports additionally give a multi-year pre-memorable for the segment and remember information for financial information of worldwide. Key partners can think about measurements, tables and figures referenced in this report for vital arranging which lead to achievement of the association.

Testosterone Replacement Therapy market detailed by definitions, orders, applications and market outline; product determinations; producing forms; cost structures, crude materials, etc. At that point it investigated the worlds principle locale economic situations, including the product value, benefit, limit, creation, gracefully, request and market development rate and conjecture and other. The report presented new undertaking SWOT investigation, venture plausibility and examination. The report additionally presents the market rivalry scene and a relating point by point investigation of the significant merchant/producers in the Testosterone Replacement Therapy showcase.

Get Exclusive Sample copy on Testosterone Replacement Therapy Market is available at https://inforgrowth.com/sample-request/983082/qyresearchglobal-testosterone-replacement-therapy-market-insights-forecast-to-2025

Testosterone Replacement Therapy Market 2020-2026: Segmentation

The Testosterone Replacement Therapy market report covers major market players like

Testosterone Replacement Therapy Market is segmented as below:

By Product Type:

Breakup by Application:

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List;https://inforgrowth.com/discount/983082/qyresearchglobal-testosterone-replacement-therapy-market-insights-forecast-to-2025

Impact of COVID-19:Testosterone Replacement TherapyMarket report analyses the impact of Coronavirus (COVID-19) on the Testosterone Replacement Therapyindustry.Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Testosterone Replacement Therapymarket in 2020.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Download the Sample ToC and understand the COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/983082/qyresearchglobal-testosterone-replacement-therapy-market-insights-forecast-to-2025

Global Testosterone Replacement TherapyMarket Report Answers Below Queries:

Advance information on Testosterone Replacement Therapy Market:

To know about the global trends impacting the future of market research, contact at: https://inforgrowth.com/enquiry/983082/qyresearchglobal-testosterone-replacement-therapy-market-insights-forecast-to-2025

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: US: +1-909-329-2808UK: +44 (203) 743 1898

Read the original here:
Global Testosterone Replacement Therapy Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: AbbVie, Endo International, Eli...

Posted in Testosterone | Comments Off on Global Testosterone Replacement Therapy Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: AbbVie, Endo International, Eli…

Get in shape during the pandemic – KTAR.com

Posted: August 18, 2020 at 11:56 am

With the stress of a pandemic along with social and political upheaval, its understandable if youve slipped into some unhealthy habits, such as eating more and exercising less than youd like.

Fortunately, its not too late to make a change. No matter if you want to bulk up, slim down, or both, you can get in shape and stay safe, with a few adjustments to your daily activities.

Move your body

Whether you lift weights at home or jog around your neighborhood, its important to move every day. Sedentary living has many health risks, including heart disease, high blood pressure, diabetes, stroke, and an increased chance of depression and anxiety, according to MedlinePlus.

Even though options are limited, as long as you have space to move, any corner of your house or yard or garage, if you have one can be your home gym. Pick a consistent time, play some music, and turn your space into a weight room, cycling studio, boxing club or whatever motivates you. Every day might look a little different, so get creative and break a sweat.

Do what you enjoy

Pandemic or not, you are more likely to consistently exercise if you choose something you enjoy. While running on a treadmill will do in a pinch for some, it may not motivate you, so mix in new activities. Whether youre doing a structured workout or dancing along to music videos, as long as it makes you happy, youll keep at it.

For motivation, online instruction can help. Free classes on the web or in apps make strength training, cycling, yoga and so on accessible. Additionally, many paid subscriptions offer a free trial, so test a few options to see what you like.

Wear a fitness tracker

Fitness trackers count your steps, measure your heart rate, track your water intake, and more. Do some research to find a tracker that will help you meet your goals.

Along with a tracker, you can get personalized help from a trainer. Even if you cant or dont want to visit a gym, you can find a trainer who creates customized workouts, live streams group sessions, or meets online for one-on-one training.

Add healthy foods to your diet

Nutrition is essential to fitness. In fact, if one of your goals has to do with your weight, what you consume is more important than how you work out.

Eating food that meets your daily nutrient needs will not only help you stay in shape but boost your mood. Whole grains, lean proteins and plenty of fresh fruits and vegetables are the building blocks to healthiness.

If you want to take it a step further, ask a dietitian to create a customized eating plan for you.

Check your hormone levels

If you eat healthy and work out but still arent seeing results, your hormones could be to blame. Fatigue, weight gain, loss of muscle, and trouble sleeping are just a few symptoms of low testosterone.

Beginning in our 30s, our bodies start to become fatigued more easily, viTal4men says. You lose muscle mass, mental sharpness and libido (sex drive) begins to decline.

Fortunately, theres an easy way to check and adjust your levels.

At the viTal4men clinic, we treat low testosterone levels with testosterone replacement therapy to get you back to your optimum level, viTal4men says. We are a complete mens wellness center.

Visit Vital4Men.com for more information and to schedule your free consultation.

More:
Get in shape during the pandemic - KTAR.com

Posted in Testosterone | Comments Off on Get in shape during the pandemic – KTAR.com

Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom – Robb Report

Posted: August 17, 2020 at 4:00 pm

Not long ago, a successful Silicon Valley tech entrepreneur decided to make a risky new investment hed been toying with for years. Id just hit 50 and sold my second company, he recalls. I looked at myself and thought, I have another 20 years of work in front of me, so Im going to go do this now.

Marc paid $25,000 for a lower face-lift and a nose job. (His name and those of the other patients who spoke to Robb Report have been changed at their request.) One of the best investments Ive made, he says. Unlike other investments in Marcs career, this one was a closely guarded secret, known only to his doctor, wife, brotherand now you.

Nine out of 10 cosmetic procedures in the US are performed on women. Yet to Marc and a growing number of high-flying men, nips, tucks and injections have become stealth weapons to deploy in a Darwinian battle for corporate survival. I play in the high-tech and start-up world, where older individuals will be passed over, says Marc, who also got his first Botox shots this year. The software wars take a lot of energy and commitment. I simply aligned my outer appearance with my inner perspective.

Its not just about advantage in a youth-oriented workplace. As gender roles evolve, vanity is losing much of its stigma for men in general. The beauty buffet, once ladies-only, is now open to all, with men increasingly moving from the hors doeuvres (grooming, beard cultivation, skin care, dieting and exercising) to the appetizers (cosmetic dentistry, hair replacement, hormone therapy) and on to the entrees (Botox, fillers, non-invasive fat reduction) before ordering up the piece de resistance: plastic surgery. Chanel, Fenty and Tom Ford now also offer a once-unthinkable side dish: makeup for men, leading them into the realm of foundation and eyebrow gel.

Tom Fords makeup for men.Tom Ford

Men dont use the word beauty, of course. Women talk about beauty. Men talk about vitality, virility, competitive edgethats a masculine way of describing what is essentially vanity, says William Liu, professor of psychology at the University of Maryland, who specializes in issues around masculinity. But what they are really talking about is warding off existential anxiety around death.

The idea of stigma has changed, says Marc. Women should not always have to look made-up, and men can wear makeup. Those mores are changing. Theres still a little bit of raising an eyebrow right now, but its becoming much more acceptable. Some people like to spend money on expensive cars. I like to spend money on myselfI consider my body to be the vehicle I drive in.

For some, cosmetic procedures fit smoothly into the narrative of personal empowerment and the growing idea that you can create yourself: your gender, your face, your identity. Its the old American idea of self-improvement, sliced and diced for the 21st century. Behavior that would once have seemed narcissistic has been reframed as an act of self-care. For starters, technology means theres no longer any need to tolerate physical imperfection. Plus, while millennials are accepting of quirky traits and would be loath to admit to holding a single ideal aesthetic, they also consider the very notion of judging other peoples lifestyle choices so old-fashioned that any taboo surrounding cosmetic enhancements seems like a relic from another era. So lets all get lip fillers.

And they will: Millennials are nearly twice as likely as people over 35 to be considering a cosmetic procedure in the next year, according to a poll last year by RealSelf, a cosmetic-surgery review website. The trend is toward transparency and removal of stigma for everything to do with self-care and self-love, says Simon Ourian, M.D., whom Kylie Jenner has credited forher signature pout with Juvederm, an investment on which Jenner has since built a nine-figure cosmetics business.

More cosmetic work is done in the United States than in any other country, according to a study by the International Society of Aesthetic Plastic Surgery. In 2018, the last year for which figures are available, the American Society of Plastic Surgeons (ASPS) reports that Americans spent a record $16.5 billion on plastic surgery and its twin progeny, Botox and fillers. Botox and other botulinum-toxin brands accounted for 42 percent of the 17.7 million procedures performed in the US by plastic surgeons that year. The real number of such injections is far higher, because they are also routinely dispensed by dentists, dermatologists, ophthalmologists and even walk-in beauty bars.

Adobe

More men are being seduced by these speedy pick-me-ups as the barriers to entry, both practical and social, diminish. In the US, male use of fillers and Botox has risen by 101 percent and 381 percent, respectively, since 2000, according to the ASPS, while the number of surgical nose jobs has dropped by 65 percent. Demand for handsome noses has not declined: Its just that many men now have their noses adjusted with less daunting fillers instead, according to Alan Matarasso, M.D., a plastic surgeon on New Yorks Upper East Side.

All the leading cosmetic surgeons and dermatologists interviewed for this article say men account for 20 to 35 percent of their clientele, a proportion that is growing while also broadening in scope. As with most style trends, gay men were the first to catch on. Then came the metrosexual type that would come in for Botox after their manicure, as David Mabrie, M.D., a facial plastic surgeon in San Francisco, recounts. Now its more mainstream guys. Guys guys. Men who a few years ago would have considered it a burden to trim a four-inch hair growing out of their ear are now smoothing their fine lines and filling their nasolabial folds.

In New York, the male clientele for Gerald Imber, M.D., has changed from largely those in entertainment to 95 percent CEOs and similarly accomplished professionals. These guys spend more on jet fuel coming to New York than they do on me, he says. Fifteen years ago, says Ourian, his Los Angeles patients were likely to be in entertainment, but the trend has completely changed and they are now from all walks of life. He adds that his practice includes ultra-wealthy businessmen, politicians, heads of state, three kings and five queens.

Even so, enough residual stigma remains that most men keep their Botox habits secret. And for some, the thrill of a clandestine hobby is part of the appeal. Marc likens it to membership in an exclusive club. One of Imbers patients, a 67-year-old real-estate developer from New Jersey, whom well call Nick, also relishes being a member of a secret elite club, in which the members are unknown even to each other. No one knows about it, he says. Thats just my masculine insecurityits a vanity issue. I work a lot with the construction industry, and no one there goes into work and says, I just had a face-lift.

Adobe

Nick felt that his jowly, hangdog face didnt match his gym-honed physique. I thought, If I cut my head off, I would look a lot younger, he says with a chuckle. But before I do that, Ill see if Dr. Imber can help. So three years ago, he took his girlfriend, whos 20 years his junior, for some couples liposuctionthat was the test runand followed up with a facelift.

I checked into the Carlyle, stayed three days, took the wrappings off and went home, Nick recalls. When I went out, I ran into people I knew at a restaurant. They asked if Id been on vacation. He describes with delight how he was asked for ID at a senior citizens lockdown shopping hour at a grocery store in the Hamptons.

Age has become elastic. On the one hand, Nick does not consider himself old at 67, but in youth-obsessed Silicon Valley, 35 is thought over the hill. There, the surgery is starting younger and younger, as tech-industry executives, who are mostly male, strive to appear relevant to their millennial overlords.

Larry Fan, M.D., a San Francisco plastic surgeon, says his clients now describe a work culture where if theyre over 30 they feel less relevant. Their work involves providing services to younger consumers, and tech luminaries are very young. My patients who are in their 50s say, Im the old guy in the room, and I dont want to feel that way. Young people have a kind of OK boomer mentality.

Fan says his male patients ask to look like Elon Musk: Hes aspirational for his work and [looks like he] has had some enhancements done, hair transplants and other things. He looks like a normal person but masculine and chiseled.

Elon MuskAP

Some of Fans patients, whom he describes as senior tech billionaires with famous names, regard cosmetic procedures as a form of bio-hacking (see here). Their mentality is: I want to live forever if I can find a way, Fan says. I believe in technology, and part of that is new treatments that help me have fewer wrinkles.

Ageism in the tech industry is not confined to Silicon Valley, according to one recruitment executive who worked with software start-ups in New York. The hiring managers were in their 30s, he explains. There are laws against saying youre looking for someone young, so instead they would say we need a culture fit. That was the number-one most important factor. Theyre looking for someone to grab a beer with. The recruiter put it down to the hubris that comes with gaining a lot of power at an early age. It means that they dont think they can learn anything from an older person. They feel invincible.

George, 53, the CEO of a large software company in the Bay Area, agrees that a youthful demeanor is a prerequisite in tech. Whatever HR says, you do look at pictures when you hire someone, and you look at their digital footprint, he says. Are they the right cultural fit? Do they take care of themselves? For better or worse, when you hire someone for a high-stress, high-performance job, part of that is their appearance.

In 2010, five years after Georges divorce from his first wife, his daughters took charge of his online dating profile. Being millennials, they said you have to look great online, he recalls. I realized that pictures had become very important, not just from a dating perspective but also on LinkedIn. That was a turning point for me.

He had dabbled in Botox but, with that revelation, became a devotee. A dermatologist who I played golf with said, If you want to stay looking like that, come in. I kept it up until I was 50, then I added fillers once a year, to keep the volume of my face, George says. Last year, he went to Sachin Parikh, M.D., a Palo Alto surgeon, for a hair transplant. George keeps the procedures private, partly as a career strategy. I dont want to talk about it because its still perceived as less manly. Also, men dont like to share tricks that may make them more competitive in the market. I do cryotherapy, I ride the Peloton every day and Ive had all the genetic testing to see what [conditions] I am predisposed to have, what foods do I process well. I see it all on the same spectrum as bio-hacking.

Adobe

The paradox of a man being furtive about a procedure he claims is akin to watching his sugar intake is surprisingly common. Talking about going to the gym is OK. Talking about getting a haircut is OK, says Imber. But cosmetic procedures are something they will do for themselves only, and they do not talk about it. In a culture of secrecy, it can be hard for surgeons to attract male clients through word of mouth. But once men are through the door, they keep coming back. Parikh describes the typical profile: The majority have dabbled in teeth whitening and skin care, and they work their way up the ladder from collagen stimulating treatments to fillers and Botox.

Hair-loss consultations can also be a gateway drug to other treatments, says Jessie Cheung, M.D., a Chicago-area dermatologist. A man will typically come in to talk about losing his hair, and we check for hormone deficiencies, she says. If their testosterone is not optimized, I will explain the benefits, and of course they want to perform better. Most clients who come for hormone therapy often get cosmetic treatments, too, and vice versa.

Other in-demand body treatments for men include CoolSculpting, a form of nonsurgical fat removal using cryotherapywildly popular, according to Fan, whose clientele for the procedure is 50 percent maleand skin tightening using ultrasound (Ultherapy) or radio frequency (FaceTite). But injectables are the money-spinner: a 12-year bull run of year-on-year double-digit growth, says Parikh.

Adobe

Paul Nassif, M.D., a facial surgeon famous for his TV appearances fixing bad surgery on the E! News show Botched, believes men are becoming more susceptible to the pressures of Instagram perfection. They are now on the same track as women, he says. Eight years ago, men were using Botox for work. Now I would say they are trying to make themselves look better on social media.

With fillers they can look like a filtered photo. We call it selfie dysmorphia. One of the biggest cosmetic trends of last year was the growth of reversal treatments for faulty fillers and surgical procedures, with liposuction revision up by 183 percent, according to RealSelf.

In New York, Matarasso is expecting a flood of business as soon as lockdown restrictions ease, after months of financiers, lawyers and such inspecting their double chins on Zoom. He believes that the crazy unemployment rate will lead to more treatments as job applicants grow desperate to gain an edge over their peers.

As demand for cosmetic enhancement rises, any remaining stigma, even among the middle-aged, seems likely to die away. When I talk about it with my close friends, I find a lot of them do it, too, says George, the software CEO. Its dont ask, dont tell, but when you do ask, they do tell.

More here:
Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom - Robb Report

Posted in Testosterone | Comments Off on Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom – Robb Report

Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends…

Posted: August 16, 2020 at 7:48 am

The research report entitled on the Global Testosterone Replacement Therapy Market offers useful understandings into the trends and factors that drive this market. This report provides wide-ranging analysis on market status and development trend, including types, applications, rising technology, and the region also it covers the current and past market scenarios, market development outlines, and is expected to proceed with a continuing development over the forecast period. A number of analysis tools such as SWOT analysis and Porters five forces analysis have been employed to provide a correct understanding of this market.

The Testosterone Replacement Therapy Market revenue was US$ XX.XX Million in 2020, and will reach XX.XX Million USD in 2024, with CAGR of x.x%, is expected to be registered during the forecast period 2020-2024.

Request Sample Copy of Testosterone Replacement Therapy Market @: https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#request_sample

Some of the Key Players of the Testosterone Replacement Therapy Market:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

This newest report, covering the current COVID-19 impact on the market. The disease of Coronavirus (COVID-19) has impacted every aspect of life totally. This has taken along with numerous changes in market conditions.

Some of the geographic regions examined in the overall Testosterone Replacement Therapy Market are:

Get Huge Discount on this Report:https://www.globalmarketers.biz/discount_inquiry/discount/129647

Testosterone Replacement Therapy Market By Type:

GelsInjectionsPatchesOther

Based on end-user/application, this report focuses on the status and outlook for major applications:

HospitalsClinicsOthers

The Testosterone Replacement Therapy Market research provides answers to the following key questions:

Inquire Before [emailprotected]https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

Key Points of this Testosterone Replacement Therapy Market report:

Fundamentals of Table of Content:

Get Full Table of Content @ https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#table_of_contents

See the article here:
Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends...

Posted in Testosterone | Comments Off on Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends…

Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,…

Posted: August 14, 2020 at 11:48 pm

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Testosterone Replacement Therapy Market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

Whats keeping AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Request a sample copy:https://www.coherentmarketinsights.com/insight/request-sample/2024

List of Companies Mentioned:AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

1) Does Study provides Latest Impact on Market due to COVID & Slowdown?

Yes study have considered a chapter on Impact Analysis and this 2020 Edition of the report provides detailed analysis and its impact on growth trends and market sizing to better understand current scenario.

2) How companies are selected or profiled in the report?

List of some players that are profiled in the the report includes AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.. list is sorted to come up with a sample size of atleast 50 to 100 companies having greater topline value to get their segment revenue for market estimation.

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Is it possible to narrow down business segments by Application of this study?

Yes, depending upon the data availability and feasibility check by our Research Analyst, further breakdown in business segments by end use application in relation to type can be provided (If applicable) by Revenue Size or Volume*.

4) What is the base year of the study? What time frame is covered in the report?

Furthermore, the years considered for the study are as follows:

Historical year 2016 2019

Base year 2019

Forecast period** 2020 to 2027 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Global Testosterone Replacement Therapy Market What to expect from this report:

Focused Study on Niche Strategy and Market Development & penetration Scenario

Analysis of M&As, Partnership & JVs in Global Testosterone Replacement Therapy Industry in United States & Other Emerging Geographies

Top 10 Global Testosterone Replacement Therapy Companies in Global Market Share Analysis: Leaders and Laggards in 2017, 2020

Gain strategic insights on competitor information to formulate effective R&D moves

Identify emerging players and create effective counter-strategies to outpace competitive edge

Identify important and diverse product types/services offering carried by major players for market development

And many more .

TABLE OF CONTENTS

Report Overview:It includes the Testosterone Replacement Therapy market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary:This section of the report gives information about Testosterone Replacement Therapy market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players:Here, key players of the Testosterone Replacement Therapy market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study:All of the regions and countries analyzed in the Testosterone Replacement Therapy market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Download PDF Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/2024

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

Mr Raj ShahCoherent Market Insights 1001 4th Ave,#3200 Seattle, WA 98154, U.S.Phone +1-206-701-6702[emailprotected]

Read more here:
Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,...

Posted in Testosterone | Comments Off on Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,…

Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy – NYU Langone Health

Posted: August 13, 2020 at 4:52 pm

For people with gender dysphoria, hormone therapy can significantly reduce mental distress and improve quality of life. NYU Langones multidisciplinary transgender program takes an intensely personalized approach to these treatments, centered on the individual patients goals, life circumstances, comorbidities, and evolving clinical response.

Although many medical centers offer gender-affirming hormone therapy, NYU Langone does so under the direction of an endocrinologist who specializes in transgender care. For these patients, the clinicians expertise can be crucial to optimizing outcomes, explains Michele B. Glodowski, MD, clinical instructor in the Department of Medicine, whose fellowship training included extensive clinical rotations at the University of Colorados Integrated Transgender Program.

Gender-affirming hormone therapy typically uses different doses and modalities from hormone replacement therapy for postmenopausal cisgender women or cisgender men with low testosterone. The risk of complications, including certain types of cancer, may be heightened as well. With testosterone, we often see weight gain, changes in LDL and HDL cholesterol, elevations in hematocrit, and increases in insulin resistance and blood pressure, Dr. Glodowski notes. Feminizing regimens, such as estradiol, can also trigger weight gain, raise the risk of cardiovascular disease, and often affect liver enzymes and triglycerides.

Besides enhancing her ability to monitor and manage side effects, Dr. Glodowskis training helps her tailor treatment to patients unique needs. Theres a whole spectrum of gender identity and gender expression, she says, so its important to provide a whole spectrum of care. It looks different for every individual. Some patients, for example, may identify as definitively male or female, others as nonbinary or gender-fluid. Some may choose to have hormone therapy in conjunction with gender confirmation surgery; others may choose hormonesor surgeryalone. And a wide range of external factors may influence patients therapeutic pathways.

Theres a whole spectrum of gender identity and gender expression, so its important to provide a whole spectrum of care.Michele B. Glodowski, MD

Even in 2020, people still lose their jobs or get kicked out of their homes because theyre trans, Dr. Glodowski observes. I want to make sure patients are comfortable with all the social aspects that can come into play with gender transition. If someone says, Im not ready to come out at work yet, we might slow the process down a bit. If they say, my parents have 30,000 questions, we might arrange a visit with mom and dad. Patients may wish to have their eggs or sperm frozen before hormone therapy begins, to preserve their fertility. Those who do sex work might benefit from screening for sexually transmitted diseases, or consultation with a social worker who can connect them with supportive services.

In collaboration with her colleagues in the multidisciplinary transgender programwhose specialties include plastic surgery, gynecology, and urology, in addition to endocrinologyDr. Glodowski is able to ensure that patients receive precisely the care they require.

NYU Langone Health has been certified for 7 consecutive yearswith a score of 100 percentby the Human Rights Campaign Foundation Healthcare Equality Index Report, which evaluates the work of medical facilities in providing equal healthcare access to LGBTQ+ Americans. One factor in that success is the centers patient-centered approach to transgender care.

In some practices, patients can walk into the office and have someone use the wrong pronoun, Dr. Glodowski says. The doctor might see them briefly, write a prescription, and thats basically it. At NYU Langone, everyone from the receptionists to the medical assistants to the physicians have been trained to be sensitive to gender identity. I spend 40 minutes with each new patient, and 20 minutes with any follow-ups. In addition, we have one clinic a week specifically dedicated to gender-affirming hormone therapy.

The 2019 coronavirus disease (COVID-19) pandemic has also made telehealth a crucial component of the transgender programs endocrinology practice. Although the crisis has waned in New York City, many patients prefer to continue with video visitsciting both safety and convenienceafter an initial in-person consultation. At the height of the pandemic, many providers turned to telehealth to limit in-person visits for non-urgent care, Dr. Glodowski explains. But there is a high rate of suicidal ideation and suicide in patients who are trans-identified. For this patient group, almost all care can be described as urgent, especially for someone whos new to hormones and may be experiencing severe dysphoria.

With those who are beginning a course of hormone therapy, Dr. Glodowski typically schedules a video visit to discuss treatment goals, the expected timeline of physiological changes, and potential side effects. We want to make sure that every patient is very well informed, she explains. As treatment progresses, she will order lab work and discuss results with patients via video link, as well as checking on therapeutic progress and the patients comfort level with the regimen.

Whether a visit is in-person or remote, she adds, its always essential that we provide patients with a safe, gender-affirming space.

See the article here:
Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy - NYU Langone Health

Posted in Testosterone | Comments Off on Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy – NYU Langone Health

Platelet rich plasma and thicker hair | Health Wellness – NorthFulton.com

Posted: August 13, 2020 at 4:52 pm

Everyone would like to have thicker hair. Well, almost everyone -- but our focus today is not on those rare unicorns whose complaint is that their hair is just too thick, too luxurious and too lustrous. This article is for the rest of us who would like to have more or thicker hair or at least stop losing what we have.

A number of treatment options have been the staple considerations for normal male and female pattern hair loss for years. For men, finasteride, minoxidil and hair transplantation have long been the most effective interventions. Womens treatment options used to be even more limited, with minoxidil alone being the main option for female pattern hair loss. However, a growing body of research supports that hormone replacement and/or platelet rich plasma injections could be the miracle grow for failing follicles!

First, a note about hormone replacement therapy: A physician named Dr. Glaser published an article in the British Journal of Dermatology in 2012 which made an observation that has unfortunately gained little attention likely because it runs counter to how people usually think about hair loss and testosterone. Dr. Glaser surveyed 285 women who had been on subcutaneous testosterone therapy for more than a year for the treatment of androgen deficiency and 63% of the women who had reported hair thinning prior to treatment reported hair thickening after treatment began. This finding has received little attention, but a 63% response rate deserves further investigation.

Several patients in my own clinic who complained of thinning hair, went on androgen replacement prescribed by their endocrinologist or ob-gyn for other reasons. These patients hair became markedly thicker and more voluminous on testosterone. Although Premier Dermatology does not offer hormone replacement therapy (HRT), androgen levels are one of the laboratory tests that we order as part of our screening panel for causes of hair loss. If we have a female hair loss patient with low androgen levels (either low or low normal), we offer referral to a physician who performs HRT for discussion of risks and benefits of a trial of androgen replacement therapy for hair loss. Results that we have seen have paralleled the 63% response rate that Dr. Glaser published.

Second and just as exciting, Platelet Rich Plasma, also known as PRP, is an option that is fast becoming an important treatment strategy for treating hair loss in both men and women, be it for common hair thinning or for certain alopecia syndromes. PRP is a blood product derived from a patients own blood. The process involves the following: A fraction of blood (up to 22ml in our practice) is drawn from the individual patient into a syringe (depends on the extent of hair loss). This is a relatively small amount compared to blood donation. The blood then is spun in a centrifuge to separate its components (White & Red Blood Cells, Platelet Rich Plasma and Platelet Poor Plasma). The Platelet Rich Plasma (PRP) is collected into a syringe. The PRP is then injected into a treatment area (the scalp for hair loss).

The basis behind PRP is that growth factors and other proteins within platelets promote healing and induce tissue regeneration and rejuvenation. Platelets contain growth factors and biologically active molecules that are normally released when platelets are outside of blood vessels such as when a person gets a cut and starts to bleed into surrounding tissue. Injecting PRP into the subdermal fat induces platelet degranulation (release of platelet contents) which causes tissue exposure to platelet growth factors. In plain terms, PRP delivers growth factors to stimulate hair follicles.

To achieve best results, PRP is performed in a series of treatments. Typically, two to three treatments are performed once per month initially. It is often recommended that treatments take place every 6 months after the initial series of treatments to continue hair regeneration and maintain or enhance results.

PRP has numerous other applications in dermatology the most common of which is as an adjunct to microneedling for skin rejuvenation or treatment of acne scars. However, PRPs greatest potential may be as a treatment to help grow or maintain hair.

At Premier Dermatology and Mohs Surgery of Atlanta, we are committed to offering scientifically-backed, effective and state of the art treatments. Kathryn Filipek, PA-C has extensive cosmetic, surgical and medical dermatology experience and is responsible for the hair loss branch of our practice. If you are interested in exploring PRP and hair loss options, call today to make an appointment with Ms. Filipek. It is our privilege to take care of you and your familys skin, vein, and hair care needs.https://premierdermatologyatlanta.com/

See more here:
Platelet rich plasma and thicker hair | Health Wellness - NorthFulton.com

Posted in Testosterone | Comments Off on Platelet rich plasma and thicker hair | Health Wellness – NorthFulton.com

Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 – The Daily Chronicle

Posted: August 13, 2020 at 4:52 pm

The Latest research report on the Global Testosterone Replacement Therapy Market 2020 sheds light on the crucial aspects influencing the advancement of the market. Not only are the market opportunities revealed, but the inhibiting factors preventing the development of the market have also been discussed, following a comprehensive summary. With a view to better inform the buyers, the report takes into consideration the various limitations and strengths of the leading companies operating in the market. Their product portfolios as well as the recent business strategies adopted by them have also been talked about. The competitive developments such as research and development activities, partnerships, product innovations, and mergers and acquisitions have been analyzed.

Testosterone Replacement Therapy Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Top players in the industry include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Key players in the Testosterone Replacement Therapy market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources.

Impact of Covid-19 in Testosterone Replacement Therapy Market: The utility-owned segment is mainly being driven by increasing financial incentives and regulatory supports from the governments globally. The current utility-owned Testosterone Replacement Therapy are affected primarily by the COVID-19 pandemic. Most of the projects in China, the US, Germany, and South Korea are delayed, and the companies are facing short-term operational issues due to supply chain constraints and lack of site access due to the COVID-19 outbreak. Asia-Pacific is anticipated to get highly affected by the spread of the COVID-19 due to the effect of the pandemic in China, Japan, and India. China is the epic center of this lethal disease. China is a major country in terms of the chemical industry.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Testosterone Replacement Therapy Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

North America (the United States, Mexico, and Canada.)

South America (Brazil etc.)

Middle East and Africa (GCC Countries and Egypt.)

Download PDF brochure of this report @https://www.coherentmarketinsights.com/insight/request-pdf/2024

Remarkable Attributes of Testosterone Replacement Therapy Market Report:

The current status of the global Testosterone Replacement Therapy market, current market & the two regional and region level.

In-Depth Understanding of Facets Activating the Development of the global Testosterone Replacement Therapy marketplace.

Current market isolation Relating to Identifying portions like Testosterone Replacement Therapy Merchandise Sort, end-use Software

The innovative perspective of this global Testosterone Replacement Therapy current market with layouts that are standard, and also prime chances.

The research of this market enticing place regarding product sales of Testosterone Replacement Therapy.

Various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Testosterone Replacement Therapy market, research and consulting firms, new entrants, and financial analysts

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

Contact US

Coherent Market Insights E-mail:[emailprotected]Tel:+1-206-701-6702Add:1001 4th Ave,#3200 Seattle, WA 98154, U.S.Website:https://www.coherentmarketinsights.com

See the original post here:
Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 - The Daily Chronicle

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 – The Daily Chronicle

Page 32«..1020..31323334..4050..»